Study Details
A Study of ASP2215 versus Salvage Chemotherapy In Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) with FLT3 Mutation
Clinicaltrials.gov ID
Astellas Study ID
2215-CL-0303
EudraCT ID
N/A
Condition
Leukemia - AML
Phase
Phase 3
Age
18 Years - N/A
Sex
Female & Male
Product
gilteritinib
Type
Interventional
Trial Dates
Jan 2018 - Mar 2026
Masking
None (Open Label)
Enrollment number
276
Phase 3 Open-label, Multicenter, Randomized Study of ASP2215 versus Salvage Chemotherapy in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) with FLT3 Mutation
Study summary
Get More Information
Would you like more information about clinical trial sites that are recruiting participants for A Study of ASP2215 versus Salvage Chemotherapy In Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) with FLT3 Mutation? Contact us by filling our your information to the right and we’ll respond to you.
Locations
Site RU501
Saint Petersburg, Russian Federation
Site SG403
Singapore, Singapore
Site CN113
Zhengzhou, China
Site CN126
Shanghai, China
Site CN133
Lanzhou, China
Site MY301
Johor Bahru, Malaysia
Site CN108
Beijing, China
Site CN122
Xi'an, China
Site CN117
Jinan, China
Site CN119
Fuzhou, China
Site MY305
George Town, Malaysia
Site TH202
Khon Kaen, Thailand
Site CN128
Nanjing, China
Site MY304
Kota Kinabalu, Malaysia
Site CN105
Wuhan, China
Site TH204
Chiang Mai, Thailand
Site CN120
Changsha, China
Site RU503
Tula, Russian Federation
Site CN102
Guangzhou, China
Site CN112
Beijing, China
Site RU506
Kemerovo, Russian Federation
Site CN110
Beijing, China
Site CN101
Tianjin, China
Site MY306
Ampang, Malaysia
Site SG401
Singapore, Singapore
Site RU507
Saint Petersburg, Russian Federation
Site CN109
Beijing, China
Site RU502
Saint-Petersburg, Russian Federation
Site TH205
Bangkok, Thailand
Site RU508
Moscow, Russian Federation
Site MY302
Kuala Lumpur, Malaysia
Site TH201
Khon Kaen, Thailand
Site SG402
Singapore, Singapore
Site TH203
Bangkok, Thailand
Site CN129
Shanghai, China
Site CN136
Zhengzhou, China
Site CN121
Guangzhou, China
Site MY303
Pulau Pinang, Malaysia
Site RU504
Krasnoyarsk, Russian Federation
Site CN125
Shenyang, China
Site RU509
Moscow, Russian Federation
Site CN131
Beijing, China
Site CN132
Zhangzhou, China
Site CN106
Qingdao, China
Site CN130
Guiyang City, China
Site CN116
Changchun, China
Site CN114
Guangzhou, China
Site CN118
Hefei, China
Site CN123
Huangpu Qu, China
Site CN107
Hangzhou, China
Site CN103
Beijing, China